FR2276832A1 - Nouvelles compositions pharmaceutiques et leur preparation - Google Patents

Nouvelles compositions pharmaceutiques et leur preparation

Info

Publication number
FR2276832A1
FR2276832A1 FR7520946A FR7520946A FR2276832A1 FR 2276832 A1 FR2276832 A1 FR 2276832A1 FR 7520946 A FR7520946 A FR 7520946A FR 7520946 A FR7520946 A FR 7520946A FR 2276832 A1 FR2276832 A1 FR 2276832A1
Authority
FR
France
Prior art keywords
preparation
pharmaceutical compositions
new pharmaceutical
new
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7520946A
Other languages
English (en)
French (fr)
Other versions
FR2276832B1 (enrdf_load_stackoverflow
Inventor
Joachim Franz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2276832A1 publication Critical patent/FR2276832A1/fr
Application granted granted Critical
Publication of FR2276832B1 publication Critical patent/FR2276832B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR7520946A 1974-07-05 1975-07-03 Nouvelles compositions pharmaceutiques et leur preparation Granted FR2276832A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH931274 1974-07-05

Publications (2)

Publication Number Publication Date
FR2276832A1 true FR2276832A1 (fr) 1976-01-30
FR2276832B1 FR2276832B1 (enrdf_load_stackoverflow) 1978-10-06

Family

ID=4350618

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7520946A Granted FR2276832A1 (fr) 1974-07-05 1975-07-03 Nouvelles compositions pharmaceutiques et leur preparation

Country Status (14)

Country Link
JP (1) JPS5132724A (enrdf_load_stackoverflow)
AU (1) AU8280175A (enrdf_load_stackoverflow)
BE (1) BE831042A (enrdf_load_stackoverflow)
DE (1) DE2528516A1 (enrdf_load_stackoverflow)
ES (1) ES439113A1 (enrdf_load_stackoverflow)
FR (1) FR2276832A1 (enrdf_load_stackoverflow)
GB (1) GB1518683A (enrdf_load_stackoverflow)
HU (1) HU170215B (enrdf_load_stackoverflow)
IL (1) IL47634A (enrdf_load_stackoverflow)
NL (1) NL7507798A (enrdf_load_stackoverflow)
NZ (1) NZ178011A (enrdf_load_stackoverflow)
SE (1) SE7507414L (enrdf_load_stackoverflow)
YU (1) YU170475A (enrdf_load_stackoverflow)
ZA (1) ZA754304B (enrdf_load_stackoverflow)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0041030A1 (fr) * 1980-05-28 1981-12-02 Pierre Fabre S.A. Compositions à usage topique contenant des alcaloides de l'ergot de seigle et de vinca rosea destinés au traitement des hyperséborrhées, ainsi que leur préparation
FR2548025A1 (fr) * 1983-07-01 1985-01-04 Nitto Electric Ind Co Excipient comprenant un adjuvant alcoolique et un solvant pour l'administration percutanee d'un agent a activite physiologique
EP0279986A1 (en) * 1987-02-26 1988-08-31 Alza Corporation Skin permeation enhancer compositions using glycerol monolaurate
EP0295411A1 (en) * 1987-05-15 1988-12-21 Sansho Co., Ltd. Pharmaceutical preparation for percutaneous administration containing eperisone or tolperisone or a salt thereof
EP0521799A1 (en) * 1991-07-05 1993-01-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ophthalmic compositions

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54163810A (en) * 1978-06-14 1979-12-26 Mundipharma Ag Gel composition for local coating
JPS56159310A (en) * 1980-05-14 1981-12-08 Showa Denko Kk Preparation of monofilament having high strength and knot strength
JPS59216825A (ja) * 1983-05-23 1984-12-06 Takeda Chem Ind Ltd 経皮吸収外用製剤
US5128376A (en) * 1983-07-01 1992-07-07 Nitto Denko Corporation Method for percutaneously administering physiologically active agents using an adjuvant a solvent and a diol moderator
US4752612A (en) * 1983-07-01 1988-06-21 Nitto Electrical Industrial Co., Ltd. Method and percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent
JPS6013720A (ja) * 1983-07-01 1985-01-24 Nitto Electric Ind Co Ltd 生理的活性剤の吸収促進剤
US4751087A (en) * 1985-04-19 1988-06-14 Riker Laboratories, Inc. Transdermal nitroglycerin delivery system
JPH0735331B2 (ja) * 1986-01-16 1995-04-19 久光製薬株式会社 外用ゲル製剤
JPH0735332B2 (ja) * 1986-02-25 1995-04-19 久光製薬株式会社 外用クリ−ム製剤
JPH0759519B2 (ja) * 1987-02-23 1995-06-28 株式会社資生堂 経皮吸収促進剤及びこれを含有する皮膚外用製剤
DE3710216A1 (de) * 1987-03-27 1988-10-06 Rentschler Arzneimittel Verwendung von dihydroergotamin und seinen salzen zur lokalen behandlung trophischer stoerungen
US5223261A (en) * 1988-02-26 1993-06-29 Riker Laboratories, Inc. Transdermal estradiol delivery system
CH679119A5 (enrdf_load_stackoverflow) * 1988-05-13 1991-12-31 Sandoz Ag
GB2230444B (en) * 1989-04-19 1993-12-08 Ritchie Swanson John Therapeutic compositions.
US5219877A (en) * 1989-09-25 1993-06-15 Bristol-Myers Squibb Company Lauryl alcohol as skin penetration enhancer for topical imidazole agents
AU7880991A (en) * 1990-05-10 1991-11-27 Novo Nordisk A/S A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols
US5397771A (en) * 1990-05-10 1995-03-14 Bechgaard International Research And Development A/S Pharmaceutical preparation
CA2175581C (en) * 1993-11-12 1999-12-14 Donald Lynn Bissett Desquamation compositions containing salicylic acid and zwitterionic compounds
US5681852A (en) * 1993-11-12 1997-10-28 The Procter & Gamble Company Desquamation compositions
US5821237A (en) * 1995-06-07 1998-10-13 The Procter & Gamble Company Compositions for visually improving skin
US6005135A (en) * 1996-03-21 1999-12-21 Exxon Chemical Patents Inc. Water-borne polymeric vehicle for coating compositions containing an amine or ammonium salt of phenolic ester alcohols
US6096326A (en) * 1997-08-15 2000-08-01 Scandinavian-American Import/Export Corporation Skin care compositions and use
ATE537811T1 (de) † 1999-02-08 2012-01-15 Intarcia Therapeutics Inc Stabile nicht wässerige einphasige visköse vehikel und formulierungen die diese vehikel verwenden
US7258869B1 (en) 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
CA2651855C (en) 2006-05-30 2011-08-02 Intarcia Therapeutics, Inc. Two-piece, internal-channel osmotic delivery system flow modulator
PT2359808E (pt) 2006-08-09 2013-08-28 Intarcia Therapeutics Inc Sistemas de entrega osmótica e montagens de pistão
IL290847B2 (en) 2007-04-23 2024-11-01 Intarcia Therapeutics Inc Suspension formulations of insulinotropic peptides and uses thereof
KR101514342B1 (ko) * 2007-11-22 2015-04-22 가부시키가이샤 메드렉스 지방산계 이온 액체를 유효성분으로 하는 외용제 조성물
WO2009102467A2 (en) 2008-02-13 2009-08-20 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
DK2462246T3 (da) 2009-09-28 2017-11-06 Intarcia Therapeutics Inc Hurtig etablering og/eller afslutning af væsentlig steady-state-lægemiddelafgivelse
JP2012020991A (ja) 2010-06-16 2012-02-02 Takasago Internatl Corp 経皮吸収促進剤、及びこれを含有する皮膚外用製剤
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
JP5820207B2 (ja) 2011-09-13 2015-11-24 日東電工株式会社 経皮吸収促進用組成物および貼付製剤
JP5820206B2 (ja) 2011-09-13 2015-11-24 日東電工株式会社 経皮吸収促進用組成物および貼付製剤
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
US20170239173A1 (en) 2014-10-30 2017-08-24 Asahi Kasei Kabushiki Kaisha Transdermal absorption enhancer and transdermal absorption enhancement aid
MA44390A (fr) 2015-06-03 2019-01-23 Intarcia Therapeutics Inc Systèmes de mise en place et de retrait d'implant
EP3458084B1 (en) 2016-05-16 2020-04-01 Intarcia Therapeutics, Inc Glucagon-receptor selective polypeptides and methods of use thereof
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
CA3049034A1 (en) 2017-01-03 2018-07-12 Intarcia Therapeutics, Inc. Methods comprising continuous administration of a glp-1 receptor agonist and co-adminstration of a drug

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0041030A1 (fr) * 1980-05-28 1981-12-02 Pierre Fabre S.A. Compositions à usage topique contenant des alcaloides de l'ergot de seigle et de vinca rosea destinés au traitement des hyperséborrhées, ainsi que leur préparation
FR2483235A1 (fr) * 1980-05-28 1981-12-04 Fabre Sa Pierre Compositions a usage topique contenant des alcaloides de l'ergot de seigle et de vinca rosea destinees au traitement des hyperseborrhees
FR2548025A1 (fr) * 1983-07-01 1985-01-04 Nitto Electric Ind Co Excipient comprenant un adjuvant alcoolique et un solvant pour l'administration percutanee d'un agent a activite physiologique
EP0279986A1 (en) * 1987-02-26 1988-08-31 Alza Corporation Skin permeation enhancer compositions using glycerol monolaurate
EP0295411A1 (en) * 1987-05-15 1988-12-21 Sansho Co., Ltd. Pharmaceutical preparation for percutaneous administration containing eperisone or tolperisone or a salt thereof
EP0521799A1 (en) * 1991-07-05 1993-01-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ophthalmic compositions

Also Published As

Publication number Publication date
SE7507414L (sv) 1976-01-07
FR2276832B1 (enrdf_load_stackoverflow) 1978-10-06
HU170215B (enrdf_load_stackoverflow) 1977-04-28
IL47634A (en) 1978-07-31
NL7507798A (nl) 1976-01-07
BE831042A (fr) 1976-01-05
DE2528516A1 (de) 1976-01-22
ZA754304B (en) 1977-02-23
ES439113A1 (es) 1977-10-16
AU8280175A (en) 1977-01-13
NZ178011A (en) 1978-07-28
YU170475A (en) 1984-02-29
GB1518683A (en) 1978-07-19
JPS5132724A (enrdf_load_stackoverflow) 1976-03-19
IL47634A0 (en) 1975-10-15

Similar Documents

Publication Publication Date Title
FR2276832A1 (fr) Nouvelles compositions pharmaceutiques et leur preparation
BE810197A (fr) Nouvelles electrodes et leur preparation
FR2327764A1 (fr) Nouvelles compositions pharmaceutiques et leur preparation
BE833044A (fr) 4-arylpiperidines 1, 3, 4 -trisubtituees et leur preparation
FR2285891A1 (fr) Nouvelles benzodiazepines et leur preparation
BE833586A (fr) Aminobenzazocines et leur preparation
BE832860A (fr) Benzo-isoquinoleine-diones et leur preparation
BE832921A (fr) Nouvelles rifamycines et leur preparation
BE829082A (fr) Nouvelles diamines, leur preparation et leur application
BE825982A (fr) Triazoloquinazolines et leur preparation
FR2290193A1 (fr) Derives de n2-naphtalenesulfonyl-l-arginine, leur preparation et compositions pharmaceutiques les contenant
FR2276833A1 (fr) Nouvelles compositions galeniques et leur preparation
FR2283689A1 (fr) Nouvelles cephamycines, leur preparation et leur application
FR2313059A1 (fr) Nouvelles solutions pharmaceutiques stables et leur preparation
FR2275207A1 (fr) Nouvelles benzylamines leur preparation et les compositions pharmaceutiques en contenant
FR2274291A1 (fr) Nouvelles compositions pharmaceutiques et procede pour leur preparation
BE826925A (fr) Nouvelles pyrrolodiazepines et leur preparation
BE840608A (fr) Nouvelles compositions pharmaceutiques
BE820256A (fr) Nouvelles phenoxyalkylamines et leur preparation
FR2287220A1 (fr) Nouvelles compositions pharmaceutiques anti-inflammatoires et leur procede de preparation
FR2285871A1 (fr) Compositions pharmaceutiques
BE831743A (fr) Nouvelles substances antibiotiques et leur preparation
BE826986A (fr) Nouvelles benzodiazepines et leur preparation
BE829153A (fr) 5-phenyl-thiazolidine-4-ones et leur preparation
BE832464A (fr) 3,4-dihydro-2h-isoquinoleine-1-thiones et leur preparation

Legal Events

Date Code Title Description
ST Notification of lapse